How ADHD medication is made in pharmacies | Four Corners

Key Concepts

• Compounded Stimulants: Medications custom-made by pharmacists to meet specific patient needs, rather than mass-produced, off-the-shelf pharmaceutical products.
• ADHD (Attention Deficit Hyperactivity Disorder): A neurodevelopmental condition increasingly diagnosed in adults.
• Pharmaceutical Compounding: The practice of preparing, mixing, or altering ingredients to create a customized medication.
• Data Visibility Gap: The challenge in tracking total ADHD medication usage due to the exclusion of compounded prescriptions from standard national reporting.

---

The Role of Compounded Stimulants in Perth

In Perth, Western Australia, pharmacists play a critical role in the treatment of ADHD by providing compounded stimulants. Unlike standard medications, these are prepared individually in pharmacies. The process requires precise calculations to ensure that each capsule is filled to 100% capacity, guaranteeing that the patient receives an accurate and even dosage. Taran Batsus, a pharmacist with over 20 years of experience in this field, notes that his practice was among the first in Perth to offer these services, which have become a cornerstone of their operations.

ADHD Prevalence and Diagnosis Trends

Western Australia currently reports some of the highest rates of ADHD medication usage in Australia. Data from the year ending June 2024 indicates that in Fremantle, 4.4% of the adult population filled prescriptions for ADHD medication.

However, experts emphasize that this figure is an underrepresentation of the true prevalence of treatment. Because the 4.4% statistic only accounts for standard, off-the-shelf prescriptions, it fails to capture the significant volume of patients utilizing compounded stimulants. Pharmacist Taran Batsus observes a notable increase in adult diagnoses, suggesting that many individuals who struggled with undiagnosed ADHD throughout their lives are now seeking and finding relief through these customized medical interventions.

The Data Visibility Challenge

A significant issue highlighted in the transcript is the lack of a "complete picture" regarding national ADHD medication consumption. Because compounded medications are prepared locally and do not follow the same reporting pathways as mass-manufactured drugs, they remain largely invisible in national health statistics. This creates a gap in public health data, making it difficult for policymakers and researchers to accurately assess the scale of ADHD treatment across Australia.

Synthesis and Conclusion

The use of compounded stimulants in Perth serves as a vital, yet under-reported, component of ADHD management. While official data shows high rates of medication use—such as the 4.4% figure in Fremantle—the reliance on compounding pharmacies means that the actual number of Australians managing ADHD with medication is likely higher. The trend reflects a broader societal shift where more adults are identifying and treating long-standing ADHD symptoms, necessitating a more robust system for tracking both standard and compounded pharmaceutical interventions to better understand the nation's mental health landscape.